SCHEMBL6594141

SCHEMBL6594141

O=C(O)c1cc(OCc2ccccc2)c2c(-c3ccccc3)ccc([N+](=O)[O-])c2n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.47
CYP11B1 P15538 2/20 0.47
CYP11B2 P19099 2/20 0.47
CTSV O60911 3/20 0.44
CTSL P07711 3/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43
DHODH Q02127 1/20 0.42
PTGER1 P34995 2/20 0.42
APP P05067 1/20 0.41
MCL1 Q07820 1/20 0.41
POLB P06746 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6594148 1.00 CYP19A1 (0.47) CYP19A1CYP11B1CYP11B2CTSVCTSL
SCHEMBL6080467 0.90 CYP19A1 (0.44) CYP19A1CYP11B1CYP11B2CTSVCTSL
SCHEMBL6590323 0.86 CTSV (0.44) CYP19A1CTSVCTSLPTGER1APP
SCHEMBL6590313 0.86 CTSV (0.44) CYP19A1CTSVCTSLPTGER1APP
SCHEMBL6594071 0.84 ALDH1A1 (0.47) MEN1KMT2AMAPTPOLBTDP1
SCHEMBL6594082 0.84 ALDH1A1 (0.47) MEN1KMT2AMAPTPOLBTDP1
SCHEMBL6590202 0.82 CTSV (0.43) CYP19A1CTSVCTSLAPPMCL1
SCHEMBL6590188 0.82 CTSV (0.43) CYP19A1CTSVCTSLAPPMCL1
SCHEMBL6592928 0.81 CTSV (0.47) CYP19A1CTSVCTSLPTGER1APP
SCHEMBL6592924 0.81 CTSV (0.47) CYP19A1CTSVCTSLPTGER1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451159-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2004-09-01 EP disclosed
WO-2003010146-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2003-02-06 WO disclosed